Kostas N Syrigos Selected Research

Kostas N Syrigos Research Topics

Disease

17	Neoplasms (Cancer) 07/2016 - 03/2008
14	Pancreatic Neoplasms (Pancreatic Cancer) 07/2016 - 09/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 01/2009
9	Colorectal Neoplasms (Colorectal Cancer) 09/2011 - 03/2008
6	Adenocarcinoma 01/2015 - 07/2011
6	Neoplasm Metastasis (Metastasis) 11/2012 - 03/2008
5	Lung Neoplasms (Lung Cancer) 11/2012 - 01/2008
4	Exanthema (Rash) 01/2013 - 03/2009
4	Hypersensitivity (Allergy) 01/2011 - 01/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 06/2011 - 01/2008
2	Cachexia 07/2014 - 12/2009
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2013 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 03/2012 - 01/2011
2	Infections 12/2011 - 09/2011
2	Hemorrhage 09/2011 - 01/2009
2	Breast Neoplasms (Breast Cancer) 06/2011 - 06/2008
2	Fatigue 03/2011 - 01/2009
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 03/2010 - 01/2009
2	Carcinogenesis 02/2010 - 04/2009
2	Pneumonia (Pneumonitis) 07/2009 - 02/2009
1	Primitive Neuroectodermal Tumors (PNET) 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 01/2013
1	Carcinoma (Carcinomatosis) 01/2013
1	Margins of Excision 01/2013
1	Chronic Disease (Chronic Diseases) 12/2012
1	Sepsis (Septicemia) 01/2012
1	Febrile Neutropenia 12/2011
1	Bacterial Infections (Bacterial Infection) 12/2011
1	Neutropenia 12/2011

Drug/Important Bio-Agent (IBA)

8	Gemcitabine FDA Link 07/2016 - 07/2009
8	Biomarkers (Surrogate Marker)IBA 01/2013 - 01/2008
7	Pharmaceutical PreparationsIBA 07/2016 - 06/2008
6	ErbB Receptors (EGF Receptor)IBA 01/2015 - 03/2009
4	Capecitabine (Xeloda)FDA Link 09/2014 - 06/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2013 - 03/2009
4	Biological ProductsIBA 12/2012 - 03/2009
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 07/2009
4	Fluorouracil (Carac)FDA LinkGeneric 10/2010 - 06/2008
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2010 - 03/2009
3	Irinotecan (Camptosar)FDA LinkGeneric 07/2016 - 06/2010
3	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 10/2009
3	Bevacizumab (Avastin)FDA Link 07/2013 - 06/2010
3	Monoclonal AntibodiesIBA 07/2013 - 06/2011
3	Proteins (Proteins, Gene)FDA Link 03/2012 - 04/2009
3	Docetaxel (Taxotere)FDA Link 01/2011 - 07/2009
2	Leucovorin (Folinic Acid)FDA Link 07/2016 - 10/2010
2	Pemetrexed (MTA)FDA Link 01/2015 - 10/2009
2	Octreotide (Sandostatin)FDA LinkGeneric 07/2014 - 07/2013
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 07/2014 - 07/2013
2	Sunitinib (Sutent)FDA Link 07/2013 - 01/2009
2	Cetuximab (Erbitux)FDA Link 01/2013 - 06/2010
2	Epidermal Growth Factor (EGF)IBA 11/2012 - 01/2011
2	VaccinesIBA 07/2012 - 03/2012
2	OsteopontinIBA 06/2010 - 05/2009
2	OsteocalcinIBA 06/2010 - 05/2009
2	Collagen Type I (Type I Collagen)IBA 06/2010 - 05/2009
2	OsteoprotegerinIBA 06/2010 - 05/2009
2	Vitamin D FDA LinkGeneric 04/2010 - 01/2010
2	Antineoplastic Agents (Antineoplastics)IBA 02/2009 - 01/2009
2	CytokinesIBA 01/2009 - 01/2008
1	Liposomes (Liposome)IBA 07/2016
1	Keratin-18 (Keratin 18)IBA 01/2015
1	Anaplastic Lymphoma KinaseIBA 01/2015
1	Megestrol Acetate (Borea)FDA LinkGeneric 07/2014
1	Dronabinol (THC)FDA LinkGeneric 07/2014
1	temsirolimus FDA Link 07/2013
1	bavituximabIBA 07/2013
1	HhAntag691IBA 07/2013
1	pasireotideIBA 07/2013
1	nimotuzumabIBA 07/2013
1	PhosphatidylserinesIBA 07/2013
1	Somatostatin Receptors (Somatostatin Receptor)IBA 07/2013
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2013
1	PlatinumIBA 01/2013
1	Etoposide (VP 16)FDA LinkGeneric 01/2013
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2012
1	TrabedersenIBA 07/2012
1	Lapatinib (GW572016)FDA Link 07/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2012
1	Carcinoembryonic AntigenIBA 07/2012
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2012
1	IpilimumabIBA 03/2012
1	EpitopesIBA 03/2012
1	MucinsIBA 03/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2012
1	ensituximabIBA 03/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2012
1	MicroRNAs (MicroRNA)IBA 03/2012
1	CTLA-4 AntigenIBA 03/2012
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2012

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 01/2015 - 06/2008
15	Therapeutics 07/2016 - 01/2008
4	Radiotherapy 01/2013 - 08/2009
2	Immunotherapy 07/2012 - 04/2010
2	Adjuvant Chemotherapy 10/2009 - 08/2009
1	Induction Chemotherapy 09/2014
1	Pancreatectomy 07/2014
1	Operative Surgical Procedures 07/2014
1	Antibiotic Prophylaxis 12/2011
1	Splenectomy 09/2011